top of page
image 21 (1).png



Abdullahi A, Frimpong, J., Cheng, M.T.K., et al. Performance of SARS COV-2 IgG Anti-N as an Independent Marker of exposure to SARS COV-2 in an Unvaccinated West African Population. Am J Trop Med Hygiene in press – 2023.


Abdullahi A, Maina UA, Ibrahim. AH, et al. Limited emergence of resistance to Integrase strand transfer inhibitors (INSTIs) in HIV-experienced patients failing dolutegravir-based antiretroviral therapy: Cross-sectional analysis from a Northeast Nigerian cohort. Journal of Antimicrobial Chemotherapy in press – 2023. 

Ferreira IATM, Lee C.Y.C, Foster C, Abdullahi A, et al. Atypical B cells and impaired SARS-CoV-2 neutralisation following booster vaccination in the elderly. Cell Reports in press2023.


Abdullahi A, Oladele D, Owusu M., et al. Antibody responses to AZD1222 vaccination in West Africa. Nature Communications, 13, 6131 - 2022.


Meng B, Abdullahi A, Ferreira IATM, et al. Altered TMPRSS2 usage by SARS-CoV-2 Omicron impacts tropism and fusogenicity. Nature 603: 706-714 - 2022.


Villa G, Owusu D, Smith C, Abdullahi, A et al. Liver steatosis and fibrosis in people with human immunodeficiency virus in West Africa and the relationship with hepatitis B virus coinfection. Hepatology Communications, Hepatology Communications, 6(11): 3036–3051 - 2022. 


I. Ferreira, S. Kemp, R. Datir, ………, A. Abdullahi, at al, SARS-CoV-2 B.1.617 mutations L452 and E484Q are not synergistic for antibody evasion, J. Infect. Dis. 224(6): 989-994 - 2021


Mlcochova P, Kemp S, Dhar M,………A. Abdullahi, et al. SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion. Nature 599: 114-119 – 2021


D. A. Collier, I. A. T. M. Ferreira, P. Kotagiri, R. Datir, E. Lim, E. Touizer, B. Meng,  A. Abdullahi,     et al. Age-related immune response heterogeneity to SARS-CoV-2 vaccine BNT162b2, Nature 596: 417-422 – 2021


G. Villa, A. Abdullahi, D. Owusu, C. Smith, M. Azumah, L. Sayeed, H. Austin, D. Awuah, A. Beloukas, D. Chadwick, R. Phillips, A.M. Geretti. Point of care viral load testing to guide immediate adherence support and subsequent re-suppression rates in a programmatic HIV setting in sub-Saharan Africa. EClinicalMedicine 18:100231 – 2020



A.M. Geretti, A. Abdullahi, O. Mafotsing Fopoussi, L. Bonnett, V. Fokom-Defo, S. Moudourou, J.Fokam, C. Kouanfack, J. Torimiro. An apparent paradox: resistance mutations in HIV-1 DNA predict improved virological responses to antiretroviral therapy. Journal of Antimicrobial Chemotherapy. 1;74(10):3011-3015 – 2019


A. Abdullahi, O. Mafotsing Fopoussi, J. Torimiro, M. Atkins, C. Kouanfack, A.M. Geretti. Hepatitis B virus (HBV) infection and re-activation during nucleos(t)ide reverse transcriptase inhibitor (NRTI)-sparing antiretroviral therapy in a high HBV endemicity setting. Open Forum Infect Dis. (1):1–8 - 2018

bottom of page